Shop

Showing 849–864 of 1289 results

• 

  Article: New oncology reimbursements in Belgium

  €3.03 Add to cart
• 

  Article: New oncology reimbursements in Belgium

  €3.03 Add to cart
• 

  Article: New oncology reimbursements in Belgium

  €3.03 Add to cart
• 

  Article: New oncology reimbursements in Belgium

  €3.03 Add to cart
• 

  Article: New oncology reimbursements in Belgium

  €3.03 Add to cart
• 

  Article: New oncology reimbursementsin Belgium

  €3.03 Add to cart
• 

  Article: New therapeutic targets in patients with advanced NSCLC

  €3.03 Add to cart
• 

  Article: New TNM classification for lung cancer

  €3.03 Add to cart
• 

  Article: Nivolumab improves survival in non-squamous NSCLC

  €3.03 Add to cart
• 

  Article: Nivolumab plus cabozantinib as new first-line treatment option for advanced renal cell carcinoma

  €3.03 Add to cart
• 

  Article: Nivolumab plus chemotherapy as a potential new standard first-line treatment option for patients with advanced gastric and oesophageal cancers

  €3.03 Add to cart
• 

  Article: Nivolumab prolongs the survival of patients with advanced renal cell cancer

  €3.03 Add to cart
• 

  Article: Nivolumab/ipilimumab-induced cerebral vasculitis in stage IIIc melanoma: A case report

  €3.03 Add to cart
• 

  Article: Non-muscle myosin IIA, a new potential molecular target to improve radiotherapy outcome for breast cancer patients

  €3.03 Add to cart
• 

  Article: Not just a ‘usual’ Li-Fraumeni syndrome

  €3.03 Add to cart
• 

  Article: Novel strategies in the management of high-risk and oligometastatic prostate cancer

  €3.03 Add to cart